Webinar: Continuous Grignard Reagent Generation and Use for a Highly Potent API

Inline PAT for Real-Time Understanding of the Start-up and Operation of a Continuous Grignard Reagent

Program události

  • Maximizing the value of every experiment
  • Learn new techniques that improve laboratory safety
  • Accelerate process understanding

Grignard reagents are ubiquitous in fine chemical synthesis. However, the majority of them are not commercially available, which requires them to be freshy made. This need, combined with the highly exothermic nature of the reaction, is an opportunity for implementing and realizing the benefits of continuous manufacturing. 

Herein we report the development of a continuous Grignard generator for a high potency API.

In this webinar, Stephen Born of Continuus Pharmaceuticals provides new techniques using inline PAT to accelerate process understanding for the continuous manufacturing of a Grignard reagent. 

Target Audience

Scientists and Engineers in Process R&D, Laboratory and EH&S managers.

Presenter

Image of Name Lastname

Stephen Born

Sr. Director of Scientific Affairs, Continuus Pharmaceuticals

Stephen Born is a Founder and the Sr. Director of Scientific Affairs at Continuus Pharmaceuticals. He has a PhD in Organic Chemistry, and had a very exciting postdoc in the Department of Chemical Engineering at MIT, in the Novartis-MIT Center for Continuous Manufacturing.